To further explore the therapeutic potential of targeting the DLEU1/ASCC2/G6PD axis in GC, we established stable MKN45 cell lines transduced with shNC, shDLEU1, or shDLEU1 in combined with shASCC2 and subcutaneously implanted them into nude mice. The gene discussed is G6PD; the disease is gastric cancer.